Brain Cancer Trial, Recruiting NCT07341464 Sponsor: Société des Produits Nestlé (SPN) Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07341464
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 1 and 15 years old, or adults aged 15 and above, who need one or more extra "bolus" (larger, less frequent) tube feeds on top of their usual tube feeding or home-blended food diet to help manage malnutrition related to a medical condition.
  • Patients who are already settled and doing well on their current tube feeding routine or home-blended diet.
  • Patients who receive their tube feeds through a gastrostomy (a feeding tube inserted directly into the stomach through the abdomen).
  • Patients or their caregivers who are willing and able to give written consent to take part in the trial.

Who may not be able to join:

  • Patients who, in the opinion of the study doctor, would not be able to follow the study plan or requirements.
  • Babies and children under 1 year of age.
  • Patients who use a nasogastric tube (a tube through the nose into the stomach) or a jejunal feeding tube (a tube that feeds into the small intestine).
  • Patients who receive all of their nutrition through a drip directly into their bloodstream (called total parenteral nutrition).
  • Patients who have a known allergy to any of the ingredients used in the trial products (confirm with trial site for the full ingredient list).
  • Patients who have serious kidney or liver problems.
  • Patients who have taken part in another clinical trial within the last 2 weeks.
  • Patients who have a known or suspected blockage or stoppage in their bowel.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +447557170649

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Société des Produits Nestlé (SPN)
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
10 November 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Measure of Gastrointestinal tolerance; Daily record of formula intake.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov